Status: current, Defined. Date: 30-Sep 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4453871000168110 | Vyndaqel (tafamidis meglumine 20 mg) capsule, 30 capsules, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4453881000168113 | Vyndaqel 20 mg capsule, 30, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Vyndaqel 20 mg capsule, 30, blister pack | Is a | Vyndaqel 20 mg capsule, 30 | true | Inferred relationship | Some | ||
| Vyndaqel 20 mg capsule, 30, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Vyndaqel 20 mg capsule, 30, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Vyndaqel 20 mg capsule, 30, blister pack | has TP | Vyndaqel | true | Inferred relationship | Some | ||
| Vyndaqel 20 mg capsule, 30, blister pack | has TPUU | Vyndaqel 20 mg capsule | true | Inferred relationship | Some | 1356041019 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Black Triangle Scheme reference set
Containered trade product pack reference set
FHIR